Since I last wrote about non-animal research methods in the media in early February, I’ve noticed the following news items relevant to the development of research methods in biomedicine that do not rely on animal testing:
New tests involving non-animal methods
European General Court backs shellfish test — Between 2005 and 2011, EU law required shellfish producers to inject mice with mollusk flesh extracts to detect and quantify the level of marine biotoxins in their catch. The European Commission officially phased out the use of mice to detect marine biotoxins at the end of 2014.
But shellfish producers in Galicia, Spain, argued that the commission’s order undermines public health and inconveniences the shellfish industry, and Spain lodged a complaint with the European General Court.
The Court dismissed Spain’s action last month, noting that EU food safety regulators have found that the continued use of mice to detect shellfish toxicity endangers public health more than the chemical tests do.
Skin allergies — The European Commission Joint Research Centre (JRC) has validated and recommended a new method which is not based on animal testing, to identify chemicals that can trigger skin allergies, estimated to affect already 20% of the population in Europe.
How do EU Member States facilitate the development, validation and promotion of alternative approaches at the national level? Links to documents that outline member states’ approaches are here.
The Ministry of Rural Affairs and Consumer Protection of Baden-Württemberg in Germany is accepting applications for research funding to a total of € 400,000 and for the 3Rs prize for exceptional contributions to reducing or refining animal experiments in research or education, which carries prize money of € 25,000. Deadline: 30 April 2015
CRACK IT is the NC3Rs response to the changing environment in the biosciences. The aim is to accelerate the availability of technologies which will deliver measurable 3Rs impacts, new marketable products and more efficient business processes.
Nine research and development consortia have been awarded up to £100,000 each, as part of the CRACK IT Challenge competition, to carry out initial work to develop innovative technology solutions that will impact on the replacement, refinement and reduction of animals in research (3Rs). Details about the grants are on the CRACK IT website.
Cosmetics Europe Research Consortium for the further development of Alternatives to Animal Testing (AAT) — The objective of the Long Range Science Strategy (LRSS) collaboration is to finance, steer and promote the successful development of AAT-based test methods and approaches for safety assessment and to facilitate their regulatory acceptance.
The toxicological endpoints that will be covered by the Consortium include the areas of skin sensitisation, eye irritation, genotoxicity, systemic toxicity and skin absorption and metabolism.
Source: Cosmetics Europe
PS — The images in this post are my own creation.